Global Hemostats Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hemostats market size is predicted to grow from US$ 3009 million in 2025 to US$ 4298 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hemostats Industry Forecast” looks at past sales and reviews total world Hemostats sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemostats sales for 2025 through 2031. With Hemostats sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostats industry.
This Insight Report provides a comprehensive analysis of the global Hemostats landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostats portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostats market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostats and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostats.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostats market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hemostats market?
What factors are driving Hemostats market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostats market opportunities vary by end market size?
How does Hemostats break out by Type, by Application?
The global Hemostats market size is predicted to grow from US$ 3009 million in 2025 to US$ 4298 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hemostats Industry Forecast” looks at past sales and reviews total world Hemostats sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemostats sales for 2025 through 2031. With Hemostats sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostats industry.
This Insight Report provides a comprehensive analysis of the global Hemostats landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostats portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostats market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostats and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostats.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostats market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
- Prehospital Treatment
- Hospital Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
What is the 10-year outlook for the global Hemostats market?
What factors are driving Hemostats market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostats market opportunities vary by end market size?
How does Hemostats break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostats Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hemostats by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hemostats by Country/Region, 2020, 2024 & 2031
2.2 Hemostats Segment by Type
2.2.1 Thrombin-Based Hemostats
2.2.2 Oxidized Regenerated Cellulose Based Hemostats
2.2.3 Combination Hemostats
2.2.4 Gelatin Based Hemostats
2.2.5 Collagen Based Hemostats
2.3 Hemostats Sales by Type
2.3.1 Global Hemostats Sales Market Share by Type (2020-2025)
2.3.2 Global Hemostats Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hemostats Sale Price by Type (2020-2025)
2.4 Hemostats Segment by Application
2.4.1 Prehospital Treatment
2.4.2 Hospital Treatment
2.5 Hemostats Sales by Application
2.5.1 Global Hemostats Sale Market Share by Application (2020-2025)
2.5.2 Global Hemostats Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hemostats Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hemostats Breakdown Data by Company
3.1.1 Global Hemostats Annual Sales by Company (2020-2025)
3.1.2 Global Hemostats Sales Market Share by Company (2020-2025)
3.2 Global Hemostats Annual Revenue by Company (2020-2025)
3.2.1 Global Hemostats Revenue by Company (2020-2025)
3.2.2 Global Hemostats Revenue Market Share by Company (2020-2025)
3.3 Global Hemostats Sale Price by Company
3.4 Key Manufacturers Hemostats Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostats Product Location Distribution
3.4.2 Players Hemostats Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOSTATS BY GEOGRAPHIC REGION
4.1 World Historic Hemostats Market Size by Geographic Region (2020-2025)
4.1.1 Global Hemostats Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hemostats Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hemostats Market Size by Country/Region (2020-2025)
4.2.1 Global Hemostats Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hemostats Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemostats Sales Growth
4.4 APAC Hemostats Sales Growth
4.5 Europe Hemostats Sales Growth
4.6 Middle East & Africa Hemostats Sales Growth
5 AMERICAS
5.1 Americas Hemostats Sales by Country
5.1.1 Americas Hemostats Sales by Country (2020-2025)
5.1.2 Americas Hemostats Revenue by Country (2020-2025)
5.2 Americas Hemostats Sales by Type (2020-2025)
5.3 Americas Hemostats Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostats Sales by Region
6.1.1 APAC Hemostats Sales by Region (2020-2025)
6.1.2 APAC Hemostats Revenue by Region (2020-2025)
6.2 APAC Hemostats Sales by Type (2020-2025)
6.3 APAC Hemostats Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemostats by Country
7.1.1 Europe Hemostats Sales by Country (2020-2025)
7.1.2 Europe Hemostats Revenue by Country (2020-2025)
7.2 Europe Hemostats Sales by Type (2020-2025)
7.3 Europe Hemostats Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostats by Country
8.1.1 Middle East & Africa Hemostats Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hemostats Revenue by Country (2020-2025)
8.2 Middle East & Africa Hemostats Sales by Type (2020-2025)
8.3 Middle East & Africa Hemostats Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostats
10.3 Manufacturing Process Analysis of Hemostats
10.4 Industry Chain Structure of Hemostats
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostats Distributors
11.3 Hemostats Customer
12 WORLD FORECAST REVIEW FOR HEMOSTATS BY GEOGRAPHIC REGION
12.1 Global Hemostats Market Size Forecast by Region
12.1.1 Global Hemostats Forecast by Region (2026-2031)
12.1.2 Global Hemostats Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hemostats Forecast by Type (2026-2031)
12.7 Global Hemostats Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Ethicon
13.1.1 Ethicon Company Information
13.1.2 Ethicon Hemostats Product Portfolios and Specifications
13.1.3 Ethicon Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ethicon Main Business Overview
13.1.5 Ethicon Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Hemostats Product Portfolios and Specifications
13.2.3 Pfizer Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Baxter International Inc.
13.3.1 Baxter International Inc. Company Information
13.3.2 Baxter International Inc. Hemostats Product Portfolios and Specifications
13.3.3 Baxter International Inc. Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Baxter International Inc. Main Business Overview
13.3.5 Baxter International Inc. Latest Developments
13.4 C. R. Bard
13.4.1 C. R. Bard Company Information
13.4.2 C. R. Bard Hemostats Product Portfolios and Specifications
13.4.3 C. R. Bard Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 C. R. Bard Main Business Overview
13.4.5 C. R. Bard Latest Developments
13.5 The Medicines Company
13.5.1 The Medicines Company Company Information
13.5.2 The Medicines Company Hemostats Product Portfolios and Specifications
13.5.3 The Medicines Company Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 The Medicines Company Main Business Overview
13.5.5 The Medicines Company Latest Developments
13.6 Anika Therapeutics
13.6.1 Anika Therapeutics Company Information
13.6.2 Anika Therapeutics Hemostats Product Portfolios and Specifications
13.6.3 Anika Therapeutics Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Anika Therapeutics Main Business Overview
13.6.5 Anika Therapeutics Latest Developments
13.7 Advanced Medical Solutions
13.7.1 Advanced Medical Solutions Company Information
13.7.2 Advanced Medical Solutions Hemostats Product Portfolios and Specifications
13.7.3 Advanced Medical Solutions Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Advanced Medical Solutions Main Business Overview
13.7.5 Advanced Medical Solutions Latest Developments
13.8 Integra LifeSciences Corporation
13.8.1 Integra LifeSciences Corporation Company Information
13.8.2 Integra LifeSciences Corporation Hemostats Product Portfolios and Specifications
13.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Integra LifeSciences Corporation Main Business Overview
13.8.5 Integra LifeSciences Corporation Latest Developments
13.9 B Braun Melsungen AG
13.9.1 B Braun Melsungen AG Company Information
13.9.2 B Braun Melsungen AG Hemostats Product Portfolios and Specifications
13.9.3 B Braun Melsungen AG Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 B Braun Melsungen AG Main Business Overview
13.9.5 B Braun Melsungen AG Latest Developments
13.10 Gelita Medical GmbH
13.10.1 Gelita Medical GmbH Company Information
13.10.2 Gelita Medical GmbH Hemostats Product Portfolios and Specifications
13.10.3 Gelita Medical GmbH Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Gelita Medical GmbH Main Business Overview
13.10.5 Gelita Medical GmbH Latest Developments
13.11 Equimedical
13.11.1 Equimedical Company Information
13.11.2 Equimedical Hemostats Product Portfolios and Specifications
13.11.3 Equimedical Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Equimedical Main Business Overview
13.11.5 Equimedical Latest Developments
13.12 Vascular Solutions
13.12.1 Vascular Solutions Company Information
13.12.2 Vascular Solutions Hemostats Product Portfolios and Specifications
13.12.3 Vascular Solutions Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vascular Solutions Main Business Overview
13.12.5 Vascular Solutions Latest Developments
13.13 Marine Polymer Technologies
13.13.1 Marine Polymer Technologies Company Information
13.13.2 Marine Polymer Technologies Hemostats Product Portfolios and Specifications
13.13.3 Marine Polymer Technologies Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Marine Polymer Technologies Main Business Overview
13.13.5 Marine Polymer Technologies Latest Developments
13.14 Z-Medica, LLC
13.14.1 Z-Medica, LLC Company Information
13.14.2 Z-Medica, LLC Hemostats Product Portfolios and Specifications
13.14.3 Z-Medica, LLC Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Z-Medica, LLC Main Business Overview
13.14.5 Z-Medica, LLC Latest Developments
13.15 CryoLife
13.15.1 CryoLife Company Information
13.15.2 CryoLife Hemostats Product Portfolios and Specifications
13.15.3 CryoLife Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 CryoLife Main Business Overview
13.15.5 CryoLife Latest Developments
13.16 BioCer Entwicklungs-GmbH.
13.16.1 BioCer Entwicklungs-GmbH. Company Information
13.16.2 BioCer Entwicklungs-GmbH. Hemostats Product Portfolios and Specifications
13.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 BioCer Entwicklungs-GmbH. Main Business Overview
13.16.5 BioCer Entwicklungs-GmbH. Latest Developments
13.17 Biom'Up SAS
13.17.1 Biom'Up SAS Company Information
13.17.2 Biom'Up SAS Hemostats Product Portfolios and Specifications
13.17.3 Biom'Up SAS Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Biom'Up SAS Main Business Overview
13.17.5 Biom'Up SAS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Hemostats Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hemostats Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofThrombin-Based Hemostats
Table 4. Major Players of Oxidized Regenerated Cellulose Based Hemostats
Table 5. Major Players of Combination Hemostats
Table 6. Major Players of Gelatin Based Hemostats
Table 7. Major Players of Collagen Based Hemostats
Table 8. Global Hemostats Sales byType (2020-2025) & (K Pcs)
Table 9. Global Hemostats Sales Market Share byType (2020-2025)
Table 10. Global Hemostats Revenue byType (2020-2025) & ($ million)
Table 11. Global Hemostats Revenue Market Share byType (2020-2025)
Table 12. Global Hemostats Sale Price byType (2020-2025) & (USD/Pcs)
Table 13. Global Hemostats Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Hemostats Sale Market Share by Application (2020-2025)
Table 15. Global Hemostats Revenue by Application (2020-2025) & ($ million)
Table 16. Global Hemostats Revenue Market Share by Application (2020-2025)
Table 17. Global Hemostats Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Hemostats Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Hemostats Sales Market Share by Company (2020-2025)
Table 20. Global Hemostats Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Hemostats Revenue Market Share by Company (2020-2025)
Table 22. Global Hemostats Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Hemostats Producing Area Distribution and Sales Area
Table 24. Players Hemostats Products Offered
Table 25. Hemostats Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Hemostats Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Hemostats Sales Market Share Geographic Region (2020-2025)
Table 30. Global Hemostats Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Hemostats Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Hemostats Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Hemostats Sales Market Share by Country/Region (2020-2025)
Table 34. Global Hemostats Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Hemostats Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Hemostats Sales Market Share by Country (2020-2025)
Table 38. Americas Hemostats Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Hemostats Sales byType (2020-2025) & (K Pcs)
Table 40. Americas Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Hemostats Sales Market Share by Region (2020-2025)
Table 43. APAC Hemostats Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Hemostats Sales byType (2020-2025) & (K Pcs)
Table 45. APAC Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Hemostats Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Hemostats Sales byType (2020-2025) & (K Pcs)
Table 49. Europe Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Hemostats Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Hemostats Sales byType (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Hemostats
Table 55. Key Market Challenges & Risks of Hemostats
Table 56. Key IndustryTrends of Hemostats
Table 57. Hemostats Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Hemostats Distributors List
Table 60. Hemostats Customer List
Table 61. Global Hemostats SalesForecast by Region (2026-2031) & (K Pcs)
Table 62. Global Hemostats RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Hemostats SalesForecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Hemostats Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Hemostats SalesForecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Hemostats Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Hemostats SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Hemostats RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Hemostats SalesForecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Hemostats RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Hemostats SalesForecast byType (2026-2031) & (K Pcs)
Table 72. Global Hemostats RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Hemostats SalesForecast by Application (2026-2031) & (K Pcs)
Table 74. Global Hemostats RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Ethicon Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 76. Ethicon Hemostats Product Portfolios and Specifications
Table 77. Ethicon Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Ethicon Main Business
Table 79. Ethicon Latest Developments
Table 80. Pfizer Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Hemostats Product Portfolios and Specifications
Table 82. Pfizer Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Baxter International Inc. Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 86. Baxter International Inc. Hemostats Product Portfolios and Specifications
Table 87. Baxter International Inc. Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Baxter International Inc. Main Business
Table 89. Baxter International Inc. Latest Developments
Table 90. C. R. Bard Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 91. C. R. Bard Hemostats Product Portfolios and Specifications
Table 92. C. R. Bard Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. C. R. Bard Main Business
Table 94. C. R. Bard Latest Developments
Table 95.The Medicines Company Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 96.The Medicines Company Hemostats Product Portfolios and Specifications
Table 97.The Medicines Company Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98.The Medicines Company Main Business
Table 99.The Medicines Company Latest Developments
Table 100. AnikaTherapeutics Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 101. AnikaTherapeutics Hemostats Product Portfolios and Specifications
Table 102. AnikaTherapeutics Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. AnikaTherapeutics Main Business
Table 104. AnikaTherapeutics Latest Developments
Table 105. Advanced Medical Solutions Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 106. Advanced Medical Solutions Hemostats Product Portfolios and Specifications
Table 107. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Advanced Medical Solutions Main Business
Table 109. Advanced Medical Solutions Latest Developments
Table 110. Integra LifeSciences Corporation Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 111. Integra LifeSciences Corporation Hemostats Product Portfolios and Specifications
Table 112. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Integra LifeSciences Corporation Main Business
Table 114. Integra LifeSciences Corporation Latest Developments
Table 115. B Braun Melsungen AG Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 116. B Braun Melsungen AG Hemostats Product Portfolios and Specifications
Table 117. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. B Braun Melsungen AG Main Business
Table 119. B Braun Melsungen AG Latest Developments
Table 120. Gelita Medical GmbH Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 121. Gelita Medical GmbH Hemostats Product Portfolios and Specifications
Table 122. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Gelita Medical GmbH Main Business
Table 124. Gelita Medical GmbH Latest Developments
Table 125. Equimedical Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 126. Equimedical Hemostats Product Portfolios and Specifications
Table 127. Equimedical Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Equimedical Main Business
Table 129. Equimedical Latest Developments
Table 130. Vascular Solutions Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 131. Vascular Solutions Hemostats Product Portfolios and Specifications
Table 132. Vascular Solutions Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Vascular Solutions Main Business
Table 134. Vascular Solutions Latest Developments
Table 135. Marine PolymerTechnologies Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 136. Marine PolymerTechnologies Hemostats Product Portfolios and Specifications
Table 137. Marine PolymerTechnologies Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Marine PolymerTechnologies Main Business
Table 139. Marine PolymerTechnologies Latest Developments
Table 140. Z-Medica, LLC Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 141. Z-Medica, LLC Hemostats Product Portfolios and Specifications
Table 142. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Z-Medica, LLC Main Business
Table 144. Z-Medica, LLC Latest Developments
Table 145. CryoLife Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 146. CryoLife Hemostats Product Portfolios and Specifications
Table 147. CryoLife Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. CryoLife Main Business
Table 149. CryoLife Latest Developments
Table 150. BioCer Entwicklungs-GmbH. Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 151. BioCer Entwicklungs-GmbH. Hemostats Product Portfolios and Specifications
Table 152. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. BioCer Entwicklungs-GmbH. Main Business
Table 154. BioCer Entwicklungs-GmbH. Latest Developments
Table 155. Biom'Up SAS Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 156. Biom'Up SAS Hemostats Product Portfolios and Specifications
Table 157. Biom'Up SAS Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Biom'Up SAS Main Business
Table 159. Biom'Up SAS Latest Developments
LIST OFFIGURES
Figure 1. Picture of Hemostats
Figure 2. Hemostats Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostats Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Hemostats Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hemostats Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hemostats Sales Market Share by Country/Region (2024)
Figure 10. Hemostats Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofThrombin-Based Hemostats
Figure 12. Product Picture of Oxidized Regenerated Cellulose Based Hemostats
Figure 13. Product Picture of Combination Hemostats
Figure 14. Product Picture of Gelatin Based Hemostats
Figure 15. Product Picture of Collagen Based Hemostats
Figure 16. Global Hemostats Sales Market Share byType in 2025
Figure 17. Global Hemostats Revenue Market Share byType (2020-2025)
Figure 18. Hemostats Consumed in PrehospitalTreatment
Figure 19. Global Hemostats Market: PrehospitalTreatment (2020-2025) & (K Pcs)
Figure 20. Hemostats Consumed in HospitalTreatment
Figure 21. Global Hemostats Market: HospitalTreatment (2020-2025) & (K Pcs)
Figure 22. Global Hemostats Sale Market Share by Application (2024)
Figure 23. Global Hemostats Revenue Market Share by Application in 2025
Figure 24. Hemostats Sales by Company in 2025 (K Pcs)
Figure 25. Global Hemostats Sales Market Share by Company in 2025
Figure 26. Hemostats Revenue by Company in 2025 ($ millions)
Figure 27. Global Hemostats Revenue Market Share by Company in 2025
Figure 28. Global Hemostats Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Hemostats Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Hemostats Sales 2020-2025 (K Pcs)
Figure 31. Americas Hemostats Revenue 2020-2025 ($ millions)
Figure 32. APAC Hemostats Sales 2020-2025 (K Pcs)
Figure 33. APAC Hemostats Revenue 2020-2025 ($ millions)
Figure 34. Europe Hemostats Sales 2020-2025 (K Pcs)
Figure 35. Europe Hemostats Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Hemostats Sales 2020-2025 (K Pcs)
Figure 37. Middle East & Africa Hemostats Revenue 2020-2025 ($ millions)
Figure 38. Americas Hemostats Sales Market Share by Country in 2025
Figure 39. Americas Hemostats Revenue Market Share by Country (2020-2025)
Figure 40. Americas Hemostats Sales Market Share byType (2020-2025)
Figure 41. Americas Hemostats Sales Market Share by Application (2020-2025)
Figure 42. United States Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Hemostats Sales Market Share by Region in 2025
Figure 47. APAC Hemostats Revenue Market Share by Region (2020-2025)
Figure 48. APAC Hemostats Sales Market Share byType (2020-2025)
Figure 49. APAC Hemostats Sales Market Share by Application (2020-2025)
Figure 50. China Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 54. India Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Hemostats Sales Market Share by Country in 2025
Figure 58. Europe Hemostats Revenue Market Share by Country (2020-2025)
Figure 59. Europe Hemostats Sales Market Share byType (2020-2025)
Figure 60. Europe Hemostats Sales Market Share by Application (2020-2025)
Figure 61. Germany Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 62.France Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Hemostats Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Hemostats Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Hemostats Sales Market Share by Application (2020-2025)
Figure 69. Egypt Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Hemostats in 2025
Figure 75. Manufacturing Process Analysis of Hemostats
Figure 76. Industry Chain Structure of Hemostats
Figure 77. Channels of Distribution
Figure 78. Global Hemostats Sales MarketForecast by Region (2026-2031)
Figure 79. Global Hemostats Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Hemostats Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Hemostats Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Hemostats Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Hemostats Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostats Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hemostats by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hemostats by Country/Region, 2020, 2024 & 2031
2.2 Hemostats Segment by Type
2.2.1 Thrombin-Based Hemostats
2.2.2 Oxidized Regenerated Cellulose Based Hemostats
2.2.3 Combination Hemostats
2.2.4 Gelatin Based Hemostats
2.2.5 Collagen Based Hemostats
2.3 Hemostats Sales by Type
2.3.1 Global Hemostats Sales Market Share by Type (2020-2025)
2.3.2 Global Hemostats Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hemostats Sale Price by Type (2020-2025)
2.4 Hemostats Segment by Application
2.4.1 Prehospital Treatment
2.4.2 Hospital Treatment
2.5 Hemostats Sales by Application
2.5.1 Global Hemostats Sale Market Share by Application (2020-2025)
2.5.2 Global Hemostats Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hemostats Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hemostats Breakdown Data by Company
3.1.1 Global Hemostats Annual Sales by Company (2020-2025)
3.1.2 Global Hemostats Sales Market Share by Company (2020-2025)
3.2 Global Hemostats Annual Revenue by Company (2020-2025)
3.2.1 Global Hemostats Revenue by Company (2020-2025)
3.2.2 Global Hemostats Revenue Market Share by Company (2020-2025)
3.3 Global Hemostats Sale Price by Company
3.4 Key Manufacturers Hemostats Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostats Product Location Distribution
3.4.2 Players Hemostats Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOSTATS BY GEOGRAPHIC REGION
4.1 World Historic Hemostats Market Size by Geographic Region (2020-2025)
4.1.1 Global Hemostats Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hemostats Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hemostats Market Size by Country/Region (2020-2025)
4.2.1 Global Hemostats Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hemostats Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemostats Sales Growth
4.4 APAC Hemostats Sales Growth
4.5 Europe Hemostats Sales Growth
4.6 Middle East & Africa Hemostats Sales Growth
5 AMERICAS
5.1 Americas Hemostats Sales by Country
5.1.1 Americas Hemostats Sales by Country (2020-2025)
5.1.2 Americas Hemostats Revenue by Country (2020-2025)
5.2 Americas Hemostats Sales by Type (2020-2025)
5.3 Americas Hemostats Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostats Sales by Region
6.1.1 APAC Hemostats Sales by Region (2020-2025)
6.1.2 APAC Hemostats Revenue by Region (2020-2025)
6.2 APAC Hemostats Sales by Type (2020-2025)
6.3 APAC Hemostats Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemostats by Country
7.1.1 Europe Hemostats Sales by Country (2020-2025)
7.1.2 Europe Hemostats Revenue by Country (2020-2025)
7.2 Europe Hemostats Sales by Type (2020-2025)
7.3 Europe Hemostats Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostats by Country
8.1.1 Middle East & Africa Hemostats Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hemostats Revenue by Country (2020-2025)
8.2 Middle East & Africa Hemostats Sales by Type (2020-2025)
8.3 Middle East & Africa Hemostats Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostats
10.3 Manufacturing Process Analysis of Hemostats
10.4 Industry Chain Structure of Hemostats
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostats Distributors
11.3 Hemostats Customer
12 WORLD FORECAST REVIEW FOR HEMOSTATS BY GEOGRAPHIC REGION
12.1 Global Hemostats Market Size Forecast by Region
12.1.1 Global Hemostats Forecast by Region (2026-2031)
12.1.2 Global Hemostats Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hemostats Forecast by Type (2026-2031)
12.7 Global Hemostats Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Ethicon
13.1.1 Ethicon Company Information
13.1.2 Ethicon Hemostats Product Portfolios and Specifications
13.1.3 Ethicon Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ethicon Main Business Overview
13.1.5 Ethicon Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Hemostats Product Portfolios and Specifications
13.2.3 Pfizer Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Baxter International Inc.
13.3.1 Baxter International Inc. Company Information
13.3.2 Baxter International Inc. Hemostats Product Portfolios and Specifications
13.3.3 Baxter International Inc. Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Baxter International Inc. Main Business Overview
13.3.5 Baxter International Inc. Latest Developments
13.4 C. R. Bard
13.4.1 C. R. Bard Company Information
13.4.2 C. R. Bard Hemostats Product Portfolios and Specifications
13.4.3 C. R. Bard Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 C. R. Bard Main Business Overview
13.4.5 C. R. Bard Latest Developments
13.5 The Medicines Company
13.5.1 The Medicines Company Company Information
13.5.2 The Medicines Company Hemostats Product Portfolios and Specifications
13.5.3 The Medicines Company Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 The Medicines Company Main Business Overview
13.5.5 The Medicines Company Latest Developments
13.6 Anika Therapeutics
13.6.1 Anika Therapeutics Company Information
13.6.2 Anika Therapeutics Hemostats Product Portfolios and Specifications
13.6.3 Anika Therapeutics Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Anika Therapeutics Main Business Overview
13.6.5 Anika Therapeutics Latest Developments
13.7 Advanced Medical Solutions
13.7.1 Advanced Medical Solutions Company Information
13.7.2 Advanced Medical Solutions Hemostats Product Portfolios and Specifications
13.7.3 Advanced Medical Solutions Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Advanced Medical Solutions Main Business Overview
13.7.5 Advanced Medical Solutions Latest Developments
13.8 Integra LifeSciences Corporation
13.8.1 Integra LifeSciences Corporation Company Information
13.8.2 Integra LifeSciences Corporation Hemostats Product Portfolios and Specifications
13.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Integra LifeSciences Corporation Main Business Overview
13.8.5 Integra LifeSciences Corporation Latest Developments
13.9 B Braun Melsungen AG
13.9.1 B Braun Melsungen AG Company Information
13.9.2 B Braun Melsungen AG Hemostats Product Portfolios and Specifications
13.9.3 B Braun Melsungen AG Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 B Braun Melsungen AG Main Business Overview
13.9.5 B Braun Melsungen AG Latest Developments
13.10 Gelita Medical GmbH
13.10.1 Gelita Medical GmbH Company Information
13.10.2 Gelita Medical GmbH Hemostats Product Portfolios and Specifications
13.10.3 Gelita Medical GmbH Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Gelita Medical GmbH Main Business Overview
13.10.5 Gelita Medical GmbH Latest Developments
13.11 Equimedical
13.11.1 Equimedical Company Information
13.11.2 Equimedical Hemostats Product Portfolios and Specifications
13.11.3 Equimedical Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Equimedical Main Business Overview
13.11.5 Equimedical Latest Developments
13.12 Vascular Solutions
13.12.1 Vascular Solutions Company Information
13.12.2 Vascular Solutions Hemostats Product Portfolios and Specifications
13.12.3 Vascular Solutions Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vascular Solutions Main Business Overview
13.12.5 Vascular Solutions Latest Developments
13.13 Marine Polymer Technologies
13.13.1 Marine Polymer Technologies Company Information
13.13.2 Marine Polymer Technologies Hemostats Product Portfolios and Specifications
13.13.3 Marine Polymer Technologies Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Marine Polymer Technologies Main Business Overview
13.13.5 Marine Polymer Technologies Latest Developments
13.14 Z-Medica, LLC
13.14.1 Z-Medica, LLC Company Information
13.14.2 Z-Medica, LLC Hemostats Product Portfolios and Specifications
13.14.3 Z-Medica, LLC Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Z-Medica, LLC Main Business Overview
13.14.5 Z-Medica, LLC Latest Developments
13.15 CryoLife
13.15.1 CryoLife Company Information
13.15.2 CryoLife Hemostats Product Portfolios and Specifications
13.15.3 CryoLife Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 CryoLife Main Business Overview
13.15.5 CryoLife Latest Developments
13.16 BioCer Entwicklungs-GmbH.
13.16.1 BioCer Entwicklungs-GmbH. Company Information
13.16.2 BioCer Entwicklungs-GmbH. Hemostats Product Portfolios and Specifications
13.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 BioCer Entwicklungs-GmbH. Main Business Overview
13.16.5 BioCer Entwicklungs-GmbH. Latest Developments
13.17 Biom'Up SAS
13.17.1 Biom'Up SAS Company Information
13.17.2 Biom'Up SAS Hemostats Product Portfolios and Specifications
13.17.3 Biom'Up SAS Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Biom'Up SAS Main Business Overview
13.17.5 Biom'Up SAS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Hemostats Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hemostats Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofThrombin-Based Hemostats
Table 4. Major Players of Oxidized Regenerated Cellulose Based Hemostats
Table 5. Major Players of Combination Hemostats
Table 6. Major Players of Gelatin Based Hemostats
Table 7. Major Players of Collagen Based Hemostats
Table 8. Global Hemostats Sales byType (2020-2025) & (K Pcs)
Table 9. Global Hemostats Sales Market Share byType (2020-2025)
Table 10. Global Hemostats Revenue byType (2020-2025) & ($ million)
Table 11. Global Hemostats Revenue Market Share byType (2020-2025)
Table 12. Global Hemostats Sale Price byType (2020-2025) & (USD/Pcs)
Table 13. Global Hemostats Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Hemostats Sale Market Share by Application (2020-2025)
Table 15. Global Hemostats Revenue by Application (2020-2025) & ($ million)
Table 16. Global Hemostats Revenue Market Share by Application (2020-2025)
Table 17. Global Hemostats Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Hemostats Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Hemostats Sales Market Share by Company (2020-2025)
Table 20. Global Hemostats Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Hemostats Revenue Market Share by Company (2020-2025)
Table 22. Global Hemostats Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Hemostats Producing Area Distribution and Sales Area
Table 24. Players Hemostats Products Offered
Table 25. Hemostats Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Hemostats Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Hemostats Sales Market Share Geographic Region (2020-2025)
Table 30. Global Hemostats Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Hemostats Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Hemostats Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Hemostats Sales Market Share by Country/Region (2020-2025)
Table 34. Global Hemostats Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Hemostats Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Hemostats Sales Market Share by Country (2020-2025)
Table 38. Americas Hemostats Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Hemostats Sales byType (2020-2025) & (K Pcs)
Table 40. Americas Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Hemostats Sales Market Share by Region (2020-2025)
Table 43. APAC Hemostats Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Hemostats Sales byType (2020-2025) & (K Pcs)
Table 45. APAC Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Hemostats Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Hemostats Sales byType (2020-2025) & (K Pcs)
Table 49. Europe Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Hemostats Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Hemostats Sales byType (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Hemostats
Table 55. Key Market Challenges & Risks of Hemostats
Table 56. Key IndustryTrends of Hemostats
Table 57. Hemostats Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Hemostats Distributors List
Table 60. Hemostats Customer List
Table 61. Global Hemostats SalesForecast by Region (2026-2031) & (K Pcs)
Table 62. Global Hemostats RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Hemostats SalesForecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Hemostats Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Hemostats SalesForecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Hemostats Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Hemostats SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Hemostats RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Hemostats SalesForecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Hemostats RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Hemostats SalesForecast byType (2026-2031) & (K Pcs)
Table 72. Global Hemostats RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Hemostats SalesForecast by Application (2026-2031) & (K Pcs)
Table 74. Global Hemostats RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Ethicon Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 76. Ethicon Hemostats Product Portfolios and Specifications
Table 77. Ethicon Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Ethicon Main Business
Table 79. Ethicon Latest Developments
Table 80. Pfizer Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Hemostats Product Portfolios and Specifications
Table 82. Pfizer Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Baxter International Inc. Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 86. Baxter International Inc. Hemostats Product Portfolios and Specifications
Table 87. Baxter International Inc. Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Baxter International Inc. Main Business
Table 89. Baxter International Inc. Latest Developments
Table 90. C. R. Bard Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 91. C. R. Bard Hemostats Product Portfolios and Specifications
Table 92. C. R. Bard Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. C. R. Bard Main Business
Table 94. C. R. Bard Latest Developments
Table 95.The Medicines Company Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 96.The Medicines Company Hemostats Product Portfolios and Specifications
Table 97.The Medicines Company Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98.The Medicines Company Main Business
Table 99.The Medicines Company Latest Developments
Table 100. AnikaTherapeutics Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 101. AnikaTherapeutics Hemostats Product Portfolios and Specifications
Table 102. AnikaTherapeutics Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. AnikaTherapeutics Main Business
Table 104. AnikaTherapeutics Latest Developments
Table 105. Advanced Medical Solutions Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 106. Advanced Medical Solutions Hemostats Product Portfolios and Specifications
Table 107. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Advanced Medical Solutions Main Business
Table 109. Advanced Medical Solutions Latest Developments
Table 110. Integra LifeSciences Corporation Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 111. Integra LifeSciences Corporation Hemostats Product Portfolios and Specifications
Table 112. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Integra LifeSciences Corporation Main Business
Table 114. Integra LifeSciences Corporation Latest Developments
Table 115. B Braun Melsungen AG Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 116. B Braun Melsungen AG Hemostats Product Portfolios and Specifications
Table 117. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. B Braun Melsungen AG Main Business
Table 119. B Braun Melsungen AG Latest Developments
Table 120. Gelita Medical GmbH Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 121. Gelita Medical GmbH Hemostats Product Portfolios and Specifications
Table 122. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Gelita Medical GmbH Main Business
Table 124. Gelita Medical GmbH Latest Developments
Table 125. Equimedical Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 126. Equimedical Hemostats Product Portfolios and Specifications
Table 127. Equimedical Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Equimedical Main Business
Table 129. Equimedical Latest Developments
Table 130. Vascular Solutions Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 131. Vascular Solutions Hemostats Product Portfolios and Specifications
Table 132. Vascular Solutions Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Vascular Solutions Main Business
Table 134. Vascular Solutions Latest Developments
Table 135. Marine PolymerTechnologies Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 136. Marine PolymerTechnologies Hemostats Product Portfolios and Specifications
Table 137. Marine PolymerTechnologies Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Marine PolymerTechnologies Main Business
Table 139. Marine PolymerTechnologies Latest Developments
Table 140. Z-Medica, LLC Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 141. Z-Medica, LLC Hemostats Product Portfolios and Specifications
Table 142. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Z-Medica, LLC Main Business
Table 144. Z-Medica, LLC Latest Developments
Table 145. CryoLife Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 146. CryoLife Hemostats Product Portfolios and Specifications
Table 147. CryoLife Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. CryoLife Main Business
Table 149. CryoLife Latest Developments
Table 150. BioCer Entwicklungs-GmbH. Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 151. BioCer Entwicklungs-GmbH. Hemostats Product Portfolios and Specifications
Table 152. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. BioCer Entwicklungs-GmbH. Main Business
Table 154. BioCer Entwicklungs-GmbH. Latest Developments
Table 155. Biom'Up SAS Basic Information, Hemostats Manufacturing Base, Sales Area and Its Competitors
Table 156. Biom'Up SAS Hemostats Product Portfolios and Specifications
Table 157. Biom'Up SAS Hemostats Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Biom'Up SAS Main Business
Table 159. Biom'Up SAS Latest Developments
LIST OFFIGURES
Figure 1. Picture of Hemostats
Figure 2. Hemostats Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostats Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Hemostats Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hemostats Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hemostats Sales Market Share by Country/Region (2024)
Figure 10. Hemostats Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofThrombin-Based Hemostats
Figure 12. Product Picture of Oxidized Regenerated Cellulose Based Hemostats
Figure 13. Product Picture of Combination Hemostats
Figure 14. Product Picture of Gelatin Based Hemostats
Figure 15. Product Picture of Collagen Based Hemostats
Figure 16. Global Hemostats Sales Market Share byType in 2025
Figure 17. Global Hemostats Revenue Market Share byType (2020-2025)
Figure 18. Hemostats Consumed in PrehospitalTreatment
Figure 19. Global Hemostats Market: PrehospitalTreatment (2020-2025) & (K Pcs)
Figure 20. Hemostats Consumed in HospitalTreatment
Figure 21. Global Hemostats Market: HospitalTreatment (2020-2025) & (K Pcs)
Figure 22. Global Hemostats Sale Market Share by Application (2024)
Figure 23. Global Hemostats Revenue Market Share by Application in 2025
Figure 24. Hemostats Sales by Company in 2025 (K Pcs)
Figure 25. Global Hemostats Sales Market Share by Company in 2025
Figure 26. Hemostats Revenue by Company in 2025 ($ millions)
Figure 27. Global Hemostats Revenue Market Share by Company in 2025
Figure 28. Global Hemostats Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Hemostats Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Hemostats Sales 2020-2025 (K Pcs)
Figure 31. Americas Hemostats Revenue 2020-2025 ($ millions)
Figure 32. APAC Hemostats Sales 2020-2025 (K Pcs)
Figure 33. APAC Hemostats Revenue 2020-2025 ($ millions)
Figure 34. Europe Hemostats Sales 2020-2025 (K Pcs)
Figure 35. Europe Hemostats Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Hemostats Sales 2020-2025 (K Pcs)
Figure 37. Middle East & Africa Hemostats Revenue 2020-2025 ($ millions)
Figure 38. Americas Hemostats Sales Market Share by Country in 2025
Figure 39. Americas Hemostats Revenue Market Share by Country (2020-2025)
Figure 40. Americas Hemostats Sales Market Share byType (2020-2025)
Figure 41. Americas Hemostats Sales Market Share by Application (2020-2025)
Figure 42. United States Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Hemostats Sales Market Share by Region in 2025
Figure 47. APAC Hemostats Revenue Market Share by Region (2020-2025)
Figure 48. APAC Hemostats Sales Market Share byType (2020-2025)
Figure 49. APAC Hemostats Sales Market Share by Application (2020-2025)
Figure 50. China Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 54. India Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Hemostats Sales Market Share by Country in 2025
Figure 58. Europe Hemostats Revenue Market Share by Country (2020-2025)
Figure 59. Europe Hemostats Sales Market Share byType (2020-2025)
Figure 60. Europe Hemostats Sales Market Share by Application (2020-2025)
Figure 61. Germany Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 62.France Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Hemostats Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Hemostats Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Hemostats Sales Market Share by Application (2020-2025)
Figure 69. Egypt Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Hemostats Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Hemostats in 2025
Figure 75. Manufacturing Process Analysis of Hemostats
Figure 76. Industry Chain Structure of Hemostats
Figure 77. Channels of Distribution
Figure 78. Global Hemostats Sales MarketForecast by Region (2026-2031)
Figure 79. Global Hemostats Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Hemostats Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Hemostats Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Hemostats Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Hemostats Revenue Market ShareForecast by Application (2026-2031)
